Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Board Fam Med ; 29(1): 69-77, 2016.
Article in English | MEDLINE | ID: mdl-26769879

ABSTRACT

BACKGROUND: The National Committee for Quality Assurance patient-centered medical home recognition program provides practices an opportunity to implement medical home activities. Understanding the costs to apply for recognition may enable practices to plan their work. METHODS: Practice coaches identified 5 exemplar practices (3 pediatric and 2 family medicine practices) that received level 3 recognition. This analysis focuses on 4 that received recognition in 2011. Clinical, informatics, and administrative staff participated in 2- to 3-hour interviews. We determined the time required to develop, implement, and maintain required activities. We categorized costs as (1) nonpersonnel, (2) developmental, (3) those used to implement activities, (4) those used to maintain activities, (5) those to document the work, and (6) consultant costs. Only incremental costs were included and are presented as costs per full-time equivalent (pFTE) provider. RESULTS: Practice size ranged from 2.5 to 10.5 pFTE providers, and payer mixes ranged from 7% to 43% Medicaid. There was variation in the distribution of costs by activity by practice, but the costs to apply were remarkably similar ($11,453-15,977 pFTE provider). CONCLUSION: The costs to apply for 2011 recognition were noteworthy. Work to enhance care coordination and close loops were highly valued. Financial incentives were key motivators. Future efforts to minimize the burden of low-value activities could benefit practices.


Subject(s)
Health Plan Implementation/economics , Patient Care Team/economics , Patient-Centered Care/economics , Quality Assurance, Health Care/economics , Costs and Cost Analysis , Health Plan Implementation/methods , Health Plan Implementation/organization & administration , Humans , North Carolina , Organizational Case Studies , Patient Care Team/organization & administration , Patient Care Team/standards , Patient-Centered Care/organization & administration , Patient-Centered Care/standards , Quality Assurance, Health Care/standards , United States
2.
Stem Cells ; 25(2): 279-88, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17008427

ABSTRACT

Hematopoietic stem cells (HSCs) have enormous potential for use in transplantation and gene therapy. However, the frequency of repopulating HSCs is often very low; thus, highly effective techniques for cell enrichment and maintenance are required to obtain sufficient cell numbers for therapeutic use and for studies of HSC physiology. Common methods of HSC enrichment use antibodies recognizing HSC surface marker antigens. Because antibodies are known to alter the physiology of other cell types, we investigated the effect of such enrichment strategies on the physiology and lineage commitment of HSCs. We sorted HSCs using a method that does not require antibodies: exclusion of Hoechst 33342 to isolate side population (SP) cells. To elucidate the effect of antibody binding on this HSC population, we compared untreated SP cells with SP cells treated with the Sca-1(+)c-Kit(+)Lin(-) (SKL) antibody cocktail prior to SP sorting. Our findings revealed that HSCs incubated with the antibody cocktail had decreased expression of the stem cell-associated genes c-Kit, Cd34, Tal-1, and Slamf1 relative to untreated SP cells or to cells treated with polyclonal isotype control antibodies. Moreover, SKL antibodies induced cycling in SP cells and diminished their ability to confer long-term hematopoietic engraftment in lethally irradiated mice. Taken together, these data suggest that antibody-based stem cell isolation procedures can have negative effects on HSC physiology.


Subject(s)
Antibodies/immunology , Antibodies/pharmacology , Antigens, Differentiation/immunology , Hematopoietic Stem Cell Transplantation , Stem Cells/drug effects , Stem Cells/immunology , Animals , Antigens, Differentiation/genetics , Ataxin-1 , Ataxins , Benzimidazoles , Cell Cycle/drug effects , Cell Cycle/radiation effects , Cell Separation , Female , Flow Cytometry , Gene Expression Regulation/drug effects , Gene Expression Regulation/radiation effects , Mice , Mice, Inbred C57BL , Nerve Tissue Proteins/immunology , Nuclear Proteins/immunology , Proto-Oncogene Proteins c-kit/immunology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Stem Cells/radiation effects , Whole-Body Irradiation
SELECTION OF CITATIONS
SEARCH DETAIL
...